Chris Jones: RCR and BNMS Join Forces to Advance Molecular Radiotherapy Research in the UK
Chris Jones/LinkedIn

Chris Jones: RCR and BNMS Join Forces to Advance Molecular Radiotherapy Research in the UK

Chris Jones, CRUK Clinician Scientist and Assistant Research Professor at the University of Cambridge, shared on LinkedIn:

“This is excellent. Really important work for The Royal College of Radiologists to be leading on with British Nuclear Medicine Society.”

 The Royal College of Radiologists (RCR), added:

“The National Cancer Plan for England identified molecular radiotherapy (MRT) as a research priority.

Last week, we partnered with the British Nuclear Medicine Society (BNMS) to bring together key partners driving MRT research across the UK for a roundtable discussion.

Together, we explored what needs to happen to ensure more patients can benefit from MRT research, including:

  • Stronger national, cross-government coordination on MRT
  • A more resilient radionuclide supply chain
  • Better use of existing networks to support the delivery of clinical trials across the UK

We look forward to sharing the outcomes of these important discussions in the new year.”

Chris Jones: RCR and BNMS Join Forces to Advance Molecular Radiotherapy Research in the UK

Chris Jones: RCR and BNMS Join Forces to Advance Molecular Radiotherapy Research in the UK